Austria is in the center of Europe and has a high quality health care system. Recently there have been major changes within the insurance system which might also have longer term impact on reimbursement. Currently reimbursement pathways are seen as more pragmatic in comparison to other countries – not only in the inpatient setting. Listen and learn from the Austrian experts Dr. Stefan Walzer and Dr. Thorsten Peske.
What does this mean for the pharmaceutical and medical device industry? MArS has created a country profile update Austria – a summary is available below – the full report is available on request.
Ultimately: Given the structural changes in the overall health care system in Austria it is not expected that there will be major changes within the frame and decision criteria by the Hauptverband and hence market access.